692 related articles for article (PubMed ID: 10909609)
1. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
[TBL] [Abstract][Full Text] [Related]
2. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
Vardi Y; Lidgi S; Moskovitz B; Levin RD
Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
[TBL] [Abstract][Full Text] [Related]
4. Progressive treatment of erectile dysfunction with intracorporeal injections of different combinations of vasoactive agents.
Shmueli J; Israilov S; Segenreich E; Baniel J; Livne P
Int J Impot Res; 1999 Feb; 11(1):15-9. PubMed ID: 10098948
[TBL] [Abstract][Full Text] [Related]
5. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Purvis K; Brekke I; Christiansen E
Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
[TBL] [Abstract][Full Text] [Related]
6. [Prostaglandin E1 in erectile dysfunction].
Porst H
Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A
Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275
[TBL] [Abstract][Full Text] [Related]
8. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
[TBL] [Abstract][Full Text] [Related]
9. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
[TBL] [Abstract][Full Text] [Related]
10. [3 years' experience with intracavernous auto-injection therapy].
Weiske WH
Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
[TBL] [Abstract][Full Text] [Related]
11. [Endocavernous drug infusions revisited].
Bellorofonte C; Ruoppolo M; Dell'Acqua S; Zaatar C; Ferri PM; Yamak R; Tagliaferri A; Tombolini P
Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):475-9. PubMed ID: 1838835
[TBL] [Abstract][Full Text] [Related]
12. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
[TBL] [Abstract][Full Text] [Related]
13. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
[TBL] [Abstract][Full Text] [Related]
15. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
[TBL] [Abstract][Full Text] [Related]
16. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
Asuar Aydillo S
Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
[No Abstract] [Full Text] [Related]
17. [Action of vasoactive drugs in male sexual impotence].
Morales JC; Elizondo B
Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
[TBL] [Abstract][Full Text] [Related]
18. [Long-term results of the treatment with intracavernous injection of vasoactive drugs].
Rodríguez Vela L; Gonzalvo Ibarra A; Gil Martínez P; Benejan Gual J; Cuesta Presedo JM; Ríoja Sanz LA
Arch Esp Urol; 1996 Apr; 49(3):257-69. PubMed ID: 8702347
[TBL] [Abstract][Full Text] [Related]
19. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
